Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCg Oncology Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 8 | -$0.67 | -$0.51 | -$0.56 |
| Q2 2026 | 4 | -$0.75 | -$0.56 | -$0.65 |
| Q3 2026 | 3 | -$0.75 | -$0.60 | -$0.68 |
| Q4 2026 | 1 | -$2.03 | $0.07 | -$0.63 |
| Q1 2027 | 1 | -$2.49 | $0.09 | -$0.77 |
| Q2 2027 | 1 | -$2.16 | $0.08 | -$0.67 |
| Q3 2027 | 1 | -$2.16 | $0.08 | -$0.67 |
| Q4 2027 | 1 | -$2.05 | $0.07 | -$0.63 |
Cg Oncology Inc. Earnings Date And Information
Cg Oncology Inc. last posted its earnings results on Friday, May 8th, 2026. The company reported $-0.71 earnings per share for the quarter, missing analysts' consensus estimates of $-0.58 by $0.13. The company had revenue of 1.08 M for the quarter and had revenue of 4.04 M for the year. Cg Oncology Inc. has generated $-2 earnings per share over the last year ($-2.08 diluted earnings per share) and currently has a price-to-earnings ratio of -33.49. Cg Oncology Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Cg Oncology Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/08/2026 | Q1 2026 | -$0.58 | -$0.71 | -0.13 | $453.03 K | $1.08 M |
| 02/27/2026 | Q4 2025 | -$0.61 | -$0.52 | 0.09 | $450.54 K | $2.32 M |
| 11/14/2025 | Q3 2025 | -$0.56 | -$0.57 | -0.01 | $59.36 K | $1.67 M |
| 08/08/2025 | Q2 2025 | -$0.49 | -$0.54 | -0.05 | $101.29 K | $0 |
| 05/13/2025 | Q1 2025 | -$0.39 | -$0.45 | -0.06 | $188.34 K | $52.00 K |
| 03/28/2025 | Q4 2024 | -$0.41 | -$0.49 | -0.08 | $106.73 K | $456.00 K |
| 09/30/2024 | Q3 2024 | N/A | -$0.30 | N/A | $113.00 K | $43.00 K |
| 08/08/2024 | Q2 2024 | -$0.42 | -$0.28 | 0.14 | $209.67 K | $111.00 K |
| 05/09/2024 | Q1 2024 | -$0.35 | -$0.25 | 0.1 | $166.67 K | $529.00 K |
| 03/26/2024 | Q4 2023 | N/A | -$0.33 | N/A | N/A | $1.00 K |
| 09/29/2023 | Q3 2023 | N/A | -$0.28 | N/A | N/A | $9.00 K |
| 06/28/2023 | Q2 2023 | N/A | -$0.17 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.13 | N/A | N/A | $194.00 K |
| 12/30/2022 | Q4 2022 | N/A | -$0.13 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cg Oncology Inc. Earnings: FAQ's
The conference call for Cg Oncology Inc.'s latest earnings report can be listened to online.
The conference call transcript for Cg Oncology Inc.'s latest earnings report can be read online.
Cg Oncology Inc. (:CGON) has a recorded annual revenue of $4.04 M.
Cg Oncology Inc. (:CGON) has a recorded net income of $-160,995,000.Cg Oncology Inc. has generated $-2.08 earnings per share over the last four quarters.
Cg Oncology Inc. (:CGON) has a price-to-earnings ratio of -33.49 and price/earnings-to-growth ratio is 0.85.